The FDA's Approach to Personal Genetics:

Tilting at Windmills (January 9, 2014)

Summary – The FDA’s warning letters to personal genetic firms undermines the ability of these firms to provide valuable information to researchers for the development of personalized medical advancements. The Department of Health and Human Services and the FDA should be reorganized to focus on exploiting technology to improve health care and lower cost, rather than undermining it at every turn. personal genetics fda approval